Risk Signals

Reviewed by Dr. Afshine Emrani, MD, FACC ·

Extra signals from routine visit labs. Each uses values from a standard checkup. They sit next to guideline risk scores such as PREVENT or SCORE2 — they do not replace them. For a 10-year heart risk estimate, ask your clinician about PREVENT.

METS-VF: metabolic score for visceral fat

Estimates visceral (deep belly) fat from age, sex, height, weight, waist and fasting glucose, triglycerides and HDL, via the METS-IR insulin-resistance index. No imaging needed. Use fasting labs.

Sex (as used in the formula)

Lab units

Formula, cut-off and evidence

METS-IR = [ln(2×FPG + TG) × BMI] / ln(HDL), glucose, TG and HDL in mg/dL
METS-VF = 4.466 + 0.011×(ln METS-IR)³ + 3.239×(ln WHtR)³ + 0.319×Sex (M=1, F=0) + 0.594×ln(Age)

  • METS-VF above 7.18 matched visceral fat over 100 cm² in healthy adults in the original validation (Mexican cohort). It is a research cut-point, not a diagnosis.
  • Cohort notes: METS-VF above 7.2 (upper quintiles) was linked to more new type 2 diabetes; METS-IR above 50.39 (top quartile) to more new type 2 diabetes. These are group findings, not your personal risk.
  • 2026: in 101,292 UK Biobank and 1,680 CHARLS adults with metabolic syndrome, higher METS-VF was associated with new cardiovascular disease (HR 1.63 and 2.11, high vs low). Association only; no shown gain over PREVENT or SCORE2.

eGDR: estimated glucose disposal rate

A surrogate for insulin sensitivity from waist, blood pressure status and HbA1c. Lower means more insulin resistance. It is not a clamp test.

Hypertension (diagnosed, or on blood-pressure medicine)
Formula

eGDR (mg/kg/min) = 21.158 − 0.09×waist (cm) − 3.407×hypertension (1/0) − 0.551×HbA1c (%)

AIP: atherogenic index of plasma

The log of triglycerides over HDL, calculated in mmol/L. Higher means a less favorable balance.

Lab units

Formula

AIP = log10(TG / HDL), mmol/L. mg/dL → mmol/L: TG ÷ 88.57, HDL ÷ 38.67

In 2026 CHARLS data (Chinese adults), lower eGDR and higher AIP were each linked to cardiometabolic multimorbidity. No validated personal cut-points are shown for eGDR or AIP.

Sources

  1. Bello-Chavolla OY et al. METS-IR. Eur J Endocrinol 2018;178(5):533-544. PMID 29535168. doi:10.1530/EJE-17-0883
  2. Bello-Chavolla OY et al. METS-VF. Clin Nutr 2020;39(5):1613-1621. PMID 31400997. doi:10.1016/j.clnu.2019.07.012
  3. Tan Z et al. BMC Cardiovasc Disord 2026;26(1):992. PMID 42958482. doi:10.1186/s12872-026-06299-2
  4. Cai H et al. BMC Cardiovasc Disord 2026;26(1):978. PMID 42934507. doi:10.1186/s12872-026-06822-5

Educational information only; not medical advice. BioHackLens does not diagnose or treat any condition. Talk with your own physician about your results.